KESHAV
EUR 216.67
2,300+ vendusPharmacie physique à Hong Kong, authenticité 100% garantie
Anamorelin, a prescription medicine targeting the ghrelin receptor GHS-R1a, was approved in Japan in January 2021 and launched in April of the same year. Use it only as directed by a physician.
10000 en stock
Indicated for adults with cancer cachexia associated with malignant tumors such as non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer.
Anamorelin Mecanisme d action Mecanisme d action ，
Please use this product according to the package instructions, pharmacist review, or your doctor’s advice. Do not adjust the dose on your own.
EMA Refused - No
Indicated for adults with cancer cachexia associated with malignant tumors such as non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer.
Please use this product according to the package instructions, pharmacist review, or your doctor’s advice. Do not adjust the dose on your own.
EMA Refused - No
Indications
Indicated for adults with cancer cachexia associated with malignant tumors such as non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer.
Mécanisme d’action
Anamorelin Mecanisme d action Mecanisme d action ，
Posologie
Please use this product according to the package instructions, pharmacist review, or your doctor’s advice. Do not adjust the dose on your own.
Precautions
EMA Refused - No
